- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00991029
Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial (POINT)
A transient ischemic attack (TIA) is a transient episode of neurological dysfunction caused by focal brain, spinal cord, or retinal ischemia, without acute infarction. An ischemic stroke is a cerebral infarction. In POINT, eligibility is limited to brain TIAs and to minor ischemic strokes (with an NIH Stroke Scale [NIHSS] score less than or equal to 3).
TIAs are common [25], and are often harbingers of disabling strokes. Approximately 250,000-350,000 TIAs are diagnosed each year in the US. Given median survival of more than 8 years [32], there are approximately 2.4 million TIA survivors. In a national survey, one in fifteen of those over 65 years old reported a history of TIA [33], which is equivalent to a prevalence of 2.3 million in older Americans. Based on the prevalence of undiagnosed transient neurological events, the true incidence of TIA may be twice as high as the rates of diagnosis [33]. Based on our review of the National Inpatient Sample for 1997-2003, there were an average of 200,000 hospital admissions for TIA each year, with annual charges climbing quickly in the period to $2.6 billion in 2003.
Composite endpoint of new ischemic vascular events: ischemic stroke, myocardial infarction or ischemic vascular death at 90 days.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Platelet-Oriented Inhibition in New TIA and minor ischemic stroke (POINT) Trial, is a prospective, randomized, double-blind, multicenter trial with the primary null hypothesis that, in patients with TIA or minor ischemic stroke treated with aspirin 50-325 mg/day, there is no difference in the event-free survival at 90 days in those treated with clopidogrel (600 mg loading dose then 75 mg/day) compared to placebo when subjects are randomized within 12 hours of time last known free of new ischemic symptoms.
Its primary objective is to determine whether clopidogrel 75 mg/day by mouth after a loading dose of 600 mg of clopidogrel is effective in preventing major ischemic vascular events (ischemic stroke, myocardial infarction, and ischemic vascular death) at 90 days when initiated within 12 hours of TIA or minor ischemic stroke onset in patients receiving aspirin 50-325 mg/day (with a dose of 150-200 mg daily for 5 days followed by 75-100 mg daily strongly recommended).
Patients over 18 years of age with high-risk TIA (defined as an ABCD2 score greater than or equal to 4) or minor ischemic stroke (with NIHSS less than or equal to 3) who can be treated within 12 hours of time last known free of new ischemic symptoms will be enrolled.
Subjects will be randomized 1:1 (clopidogrel: placebo), controlling for clinical center. A study participant's eligibility will be determined by site personnel prior to accessing the Randomization Module in the WebDCU™, a web-enabled clinical trials management system that was developed by the NETT Statistics and Data Management Center (SDMC) at Medical University of South Carolina (MUSC).Qualified users will access the Randomization Interface and complete a protocol-specific eligibility checklist. If the Randomization Interface finds the patient to be eligible based on the information provided, a randomization number and a confirmatory e-mail are generated.
Each subject is followed for 90 days from randomization; the trial will be completed in 7 years.
A total of 5,840 patients will be recruited. Recruitment will occur over 90 months, with a goal rate of 0.40 subjects/site/month for US sites, and a goal rate of 0.47 subjects/site/month for OUS sites. Current participating sites can be found at: http://www.pointtrial.org/node/18.
Study Type
Enrollment (Actual)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
New South Wales
-
Gosford, New South Wales, Australia
- Gosford Hospital
-
New Lambton, New South Wales, Australia
- John Hunter Hospital
-
-
South Australia
-
Adelaide, South Australia, Australia
- Royal Adelaide Hospital
-
-
Victoria
-
Box Hill, Victoria, Australia
- Box Hill Hospital
-
Clayton, Victoria, Australia
- Monash Medical Centre
-
Epping, Victoria, Australia
- The Northern Hospital
-
Footscray, Victoria, Australia
- Footscray Hospital
-
Heidelberg, Victoria, Australia
- Austin Hospital
-
Parkville, Victoria, Australia
- Royal Melbourne Hospital
-
-
-
-
-
Quebec, Canada
- Enfant-Jésus Hospital
-
-
Alberta
-
Calgary, Alberta, Canada
- University of Calgary - Foothills Campus
-
Edmonton, Alberta, Canada
- University of Alberta Hospital
-
Edmonton, Alberta, Canada
- Grey Nuns Hospital
-
-
British Columbia
-
Vancouver, British Columbia, Canada
- Vancouver General Hospital
-
-
Ontario
-
London, Ontario, Canada
- London Health Sciences Center
-
-
Quebec
-
Greenfield Park, Quebec, Canada
- Charles LeMoyne Hospital
-
Montreal, Quebec, Canada
- Montreal General Hospital
-
Montreal, Quebec, Canada
- Notre-Dame Hospital
-
-
-
-
-
Helsinki, Finland
- Helsinki University Central Hospital
-
Turku, Finland
- Turku University Hospital
-
-
-
-
-
Bourg-en-Bresse, France
- Fleyriat Hospital
-
Bron, France
- Pierre Wetheimer Hospital
-
Paris, France
- Pitié-Salpêtrière Hospital
-
Paris, France
- Bichat-Claude Bernard Hospital
-
Paris, France
- Adolphe de Rothschild Ophthalmologic Foundation
-
Suresnes, France
- Foch Hospital
-
-
-
-
-
Bad Neustadt an der Saale, Germany
- Neurological Clinic Bad Neustadt
-
Berlin, Germany
- Vivantes Hospital Neukölln
-
Bremen, Germany
- Central Bremen Hospital
-
Essen, Germany
- University Hospital Essen
-
Frankfurt, Germany
- University Hospital Frankfurt
-
Hamburg, Germany
- University Medical Center Hamburg
-
Hannover, Germany
- Hannover Medical School
-
Heidelberg, Germany
- University Hospital Heidelberg
-
Kiel, Germany
- University Hospital Schleswig-Holstein Kiel Campus
-
Leipzig, Germany
- University Medical Center Leipzig
-
Munster, Germany
- University Hospital Münster
-
-
Baden-Württemberg
-
Ulm, Baden-Württemberg, Germany, 89081
- University Hospital of Ulm
-
-
-
-
-
Mexico City, Mexico
- ABC Medical Center Santa Fe
-
-
Hidalgo
-
Pachuca, Hidalgo, Mexico
- Mexican Association for Clinical Research
-
-
San Luis Potosi
-
San Luis Potosí, San Luis Potosi, Mexico, 78240
- Central Hospital Dr. Ignacio Morones Prieto
-
-
Sinaloa
-
Culiacan, Sinaloa, Mexico
- Culiacan General Hospital
-
Culiacan, Sinaloa, Mexico
- Neurosciences Clinical Trials
-
-
-
-
-
Auckland, New Zealand
- Auckland City Hospital
-
-
-
-
-
Barcelona, Spain
- Hospital del Mar
-
Barcelona, Spain
- Vall d'Hebron Hospital
-
Barcelona, Spain
- Santa Creu and Sant Pau Hospital
-
Bilbao, Spain
- Basurto Hospital
-
Burgos, Spain
- Burgos University Hospital
-
Donostia, Spain
- Hospital Donostia
-
Girona, Spain
- Girona University Hospital
-
Valencia, Spain
- La Fe University Hospital
-
Zaragoza, Spain
- Miguel Servet Hospital
-
-
-
-
-
Cambridge, United Kingdom
- Addenbrooke's Hospital
-
Glasgow, United Kingdom
- Queen Elizabeth University Hospital
-
Harrow, United Kingdom
- Northwick Park Hospital
-
London, United Kingdom
- The Royal London Hospital
-
London, United Kingdom
- University College Hospital
-
Luton, United Kingdom
- Luton and Dunstable University Hospital
-
Oxford, United Kingdom
- John Radcliffe Hospital
-
Somerset, United Kingdom
- Royal United Hospital - Bath
-
Southampton, United Kingdom
- Southampton General Hospital
-
Stoke-on-Trent, United Kingdom
- Royal Stoke University Hospital
-
-
-
-
Arizona
-
Chandler, Arizona, United States, 85224
- Chandler Regional Medical Center
-
Tucson, Arizona, United States, 85724
- Banner University Medical Center - Tucson Campus
-
-
California
-
Carmichael, California, United States, 95608
- Mercy San Juan Medical Center
-
La Jolla, California, United States, 92037
- UCSD Health La Jolla
-
Loma Linda, California, United States, 92354
- Loma Linda University Medical Center
-
Long Beach, California, United States, 90806
- Long Beach Memorial Medical Center
-
Los Angeles, California, United States, 90048
- Cedars-Sinai Medical Center
-
Los Angeles, California, United States, 90027
- Kaiser Permanente Los Angeles Medical Center
-
Los Angeles, California, United States, 90095
- Ronald Reagan UCLA Medical Center
-
Palm Springs, California, United States, 92262
- Desert Regional Medical Center
-
Pasadena, California, United States, 91105
- Huntington Memorial Hospital
-
Sacramento, California, United States, 95817
- UC Davis Medical Center
-
Sacramento, California, United States, 95819
- Mercy General Hospital
-
San Diego, California, United States, 92103
- Scripps Mercy Hospital San Diego
-
San Diego, California, United States, 92103
- UCSD Medical Center - Hillcrest Hospital
-
San Francisco, California, United States, 94110
- San Francisco General Hospital
-
San Francisco, California, United States, 94143
- UCSF Medical Center
-
Stanford, California, United States, 94305
- Stanford University Medical Center
-
Thousand Oaks, California, United States, 91360
- Los Robles Hospital and Medical Center
-
-
Colorado
-
Aurora, Colorado, United States, 80045
- University of Colorado Hospital
-
Englewood, Colorado, United States, 80113
- Swedish Medical Center
-
Lakewood, Colorado, United States, 80228
- St. Anthony Hospital
-
-
Connecticut
-
New Haven, Connecticut, United States, 06510
- Yale-New Haven Hospital
-
-
Delaware
-
Newark, Delaware, United States, 19713
- Christiana Hospital
-
-
District of Columbia
-
Washington, District of Columbia, United States, 20037
- George Washington University Hospital
-
-
Florida
-
Gainesville, Florida, United States, 32608
- UF Health Shands Hospital
-
Jacksonville, Florida, United States, 32209
- University of Florida
-
Sarasota, Florida, United States, 34239
- Sarasota Memorial Hospital
-
-
Georgia
-
Atlanta, Georgia, United States, 30322
- Emory University Hospital
-
Atlanta, Georgia, United States, 30303
- Grady Memorial Hospital
-
Atlanta, Georgia, United States, 30308
- Emory University Hospital Midtown
-
Augusta, Georgia, United States, 30912
- Augusta University Medical Center
-
-
Hawaii
-
Honolulu, Hawaii, United States, 96813
- The Queen's Medical Center
-
-
Illinois
-
Chicago, Illinois, United States, 60612
- Rush University Medical Center
-
Chicago, Illinois, United States, 60611
- Northwestern Memorial Hospital
-
Chicago, Illinois, United States, 60612
- University of Illinois Hospital
-
Elk Grove Village, Illinois, United States, 60007
- Alexian Brothers Medical Center
-
Evanston, Illinois, United States, 60201
- Evanston Hospital
-
Glenview, Illinois, United States, 60026
- NorthShore Glenbrook Hospital
-
Joliet, Illinois, United States, 60435
- Presence Saint Joseph Medical Center
-
Maywood, Illinois, United States, 60153
- Loyola University Medical Center
-
Springfield, Illinois, United States, 62781
- Southern Illinois University Memorial Medical Center
-
-
Iowa
-
Iowa City, Iowa, United States, 52242
- University of Iowa Hospitals and Clinics
-
-
Kansas
-
Kansas City, Kansas, United States, 66160
- University of Kansas Hospital
-
-
Kentucky
-
Edgewood, Kentucky, United States, 41017
- St. Elizabeth Medical Center South
-
Florence, Kentucky, United States, 41042
- St. Elizabeth Hospital
-
Fort Thomas, Kentucky, United States, 41075
- St. Elizabeth Hospital Fort Thomas
-
Lexington, Kentucky, United States, 40536
- University of Kentucky Hospital
-
Louisville, Kentucky, United States, 40202
- University of Louisville Hospital
-
-
Maryland
-
Baltimore, Maryland, United States, 21201
- University of Maryland Medical Center
-
Frederick, Maryland, United States, 21701
- Frederick Memorial Hospital
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02215
- Beth Israel Deaconess Medical Center
-
Boston, Massachusetts, United States, 02115
- Brigham and Women's Hospital
-
Boston, Massachusetts, United States, 02114
- Massachusetts General Hospital
-
Boston, Massachusetts, United States, 02118
- Boston Medical Center
-
Worcester, Massachusetts, United States, 01655
- Umass Memorial Medical Center
-
-
Michigan
-
Detroit, Michigan, United States, 48202
- Henry Ford Hospital
-
Detroit, Michigan, United States, 48201
- Harper University Hospital
-
Detroit, Michigan, United States, 48236
- St. John Hospital and Medical Center
-
Detroit, Michigan, United States, 48201
- Detroit Receiving Hospital
-
Detroit, Michigan, United States, 48235
- Sinai-Grace Hospital
-
Grand Rapids, Michigan, United States, 49503
- Mercy Health Saint Mary's
-
Royal Oak, Michigan, United States, 48073
- William Beaumont Hospital
-
Troy, Michigan, United States, 48085
- William Beaumont Hospital - Troy
-
West Bloomfield, Michigan, United States, 48322
- Henry Ford West Bloomfield Hospital
-
-
Minnesota
-
Edina, Minnesota, United States, 55435
- Fairview Southdale Hospital
-
Minneapolis, Minnesota, United States, 55415
- Hennepin County Medical Center
-
Minneapolis, Minnesota, United States, 55407
- Abbott Northwestern Hospital
-
Minneapolis, Minnesota, United States, 55454
- University of Minnesota Medical Center Hospital
-
Rochester, Minnesota, United States, 55902
- Mayo Clinic Saint Mary's Campus
-
Saint Paul, Minnesota, United States, 55102
- United Hospital
-
-
Missouri
-
Saint Louis, Missouri, United States, 63110
- Barnes Jewish Hospital
-
Saint Louis, Missouri, United States, 63141
- Mercy Hospital
-
Springfield, Missouri, United States, 65804
- Mercy Hospital
-
-
Montana
-
Great Falls, Montana, United States, 59405
- Benefis Hospitals Inc
-
Great Falls, Montana, United States, 59405
- Great Falls Clinic Hospital, Great Falls
-
-
New Hampshire
-
Lebanon, New Hampshire, United States, 03766
- Dartmouth-Hitchcock Medical Center
-
-
New Jersey
-
Camden, New Jersey, United States, 08103
- Cooper University Hospital
-
Edison, New Jersey, United States, 08820
- JFK Medical Center
-
Hackensack, New Jersey, United States, 07601
- Hackensack University Medical Center
-
Neptune, New Jersey, United States, 07753
- Jersey Shore University Medical Center
-
New Brunswick, New Jersey, United States, 08901
- Robert Wood Johnson University Hospital
-
-
New York
-
Bronx, New York, United States, 10451
- Lincoln Medical and Mental Health Center
-
Brooklyn, New York, United States, 11219
- Maimonides Medical Center
-
Brooklyn, New York, United States, 11203
- SUNY Downstate Medical Center
-
Brooklyn, New York, United States, 11203
- Kings County Hospital Center
-
Buffalo, New York, United States, 14203
- Buffalo General Medical Center
-
New York, New York, United States, 10065
- NYP Weill Cornell Medical Center
-
New York, New York, United States, 10032
- New York Presbyterian / Columbia University Medical Center
-
Rochester, New York, United States, 14621
- Rochester General Hospital
-
Rochester, New York, United States, 14642
- Strong Memorial Hospital
-
Stony Brook, New York, United States, 11794
- Stony Brook University Hospital
-
Syracuse, New York, United States, 13210
- SUNY Upstate Medical University
-
-
North Carolina
-
Greensboro, North Carolina, United States, 27405
- Guilford Neurologic Associates
-
Winston-Salem, North Carolina, United States, 27157
- Wake Forest Baptist Medical Center
-
-
Ohio
-
Akron, Ohio, United States, 44304
- Summa Akron City Hospital
-
Cincinnati, Ohio, United States, 45219
- University of Cincinnati Medical Center
-
Cincinnati, Ohio, United States, 45242
- Bethesda North Hospital
-
Cincinnati, Ohio, United States, 45220
- Good Samaritan Hospital
-
Cincinnati, Ohio, United States, 45219
- Christ Hospital
-
Cincinnati, Ohio, United States, 45236
- Jewish Hospital
-
Cincinnati, Ohio, United States, 45211
- Mercy Health West Hospital
-
Cleveland, Ohio, United States, 44195
- Cleveland Clinic
-
Cleveland, Ohio, United States, 44109
- MetroHealth Medical Center
-
Columbus, Ohio, United States, 43213
- Mount Carmel East Hospital
-
Columbus, Ohio, United States, 43210
- OSU Wexner Medical Center
-
Dayton, Ohio, United States, 45409
- Miami Valley Hospital
-
Toledo, Ohio, United States, 43614
- University of Toledo Medical Center
-
-
Oregon
-
Portland, Oregon, United States, 97213
- Providence Portland Medical Center
-
Portland, Oregon, United States, 97225
- Providence St. Vincent Medical Center
-
Portland, Oregon, United States, 97239
- Oregon Health and Science University Hospital
-
Portland, Oregon, United States, 97239
- Portland VA Medical Center
-
-
Pennsylvania
-
Abington, Pennsylvania, United States, 19001
- Abington Memorial Hospital
-
Allentown, Pennsylvania, United States, 18103
- Lehigh Valley Hospital
-
Hershey, Pennsylvania, United States, 17033
- Pennsylvania State Hershey Medical Center
-
Philadelphia, Pennsylvania, United States, 19104
- Hospital of the University of Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19107
- Thomas Jefferson University Hospital
-
Philadelphia, Pennsylvania, United States, 19140
- Temple University Hospital
-
Philadelphia, Pennsylvania, United States, 19104
- Penn Presbyterian Medical Center
-
Philadelphia, Pennsylvania, United States, 19107
- Pennsylvania Hospital
-
Philadelphia, Pennsylvania, United States, 19102
- Hahnemann University Hospital
-
Pittsburgh, Pennsylvania, United States, 15213
- UPMC Presbyterian Hospital
-
Pittsburgh, Pennsylvania, United States, 15232
- UPMC Shadyside Hospital
-
York, Pennsylvania, United States, 17403
- Wellspan York Hospital
-
-
Rhode Island
-
Providence, Rhode Island, United States, 02903
- Rhode Island Hospital
-
-
South Carolina
-
Charleston, South Carolina, United States, 29425
- Medical University of South Carolina University Hospital
-
Columbia, South Carolina, United States, 29203
- Palmetto Health Richland
-
-
Tennessee
-
Nashville, Tennessee, United States, 37323
- Vanderbilt University Hospital
-
-
Texas
-
Austin, Texas, United States, 78705
- Seton Medical Center
-
Austin, Texas, United States, 78701
- University Medical Center Brackenridge
-
Dallas, Texas, United States, 75231
- Texas Health Presbyterian Hospital - Dallas
-
Harlingen, Texas, United States, 78550
- Valley Baptist Medical Center - Harlingen
-
Houston, Texas, United States, 77030
- Houston Methodist Hospital
-
Houston, Texas, United States, 77030
- Memorial Hermann Texas Medical Center
-
Houston, Texas, United States, 77030
- Ben Taub General Hospital
-
San Antonio, Texas, United States, 78229
- University of Texas Health Science Center San Antonio
-
-
Virginia
-
Charlottesville, Virginia, United States, 22908
- UVA Medical Center
-
Richmond, Virginia, United States, 23226
- Bon Secours St. Mary's Hospital
-
Richmond, Virginia, United States, 23229
- Henrico Doctors' Hospital - Forest Campus
-
Richmond, Virginia, United States, 23294
- Henrico Doctors' Hospital - Parham Campus
-
Richmond, Virginia, United States, 23114
- Bon Secours St. Francis Medical Center
-
-
Washington
-
Seattle, Washington, United States, 98195
- University of Washington Medical Center
-
Seattle, Washington, United States, 98104
- Harborview Medical Center
-
-
West Virginia
-
Morgantown, West Virginia, United States, 26505
- WVU Healthcare Ruby Memorial Hospital
-
-
Wisconsin
-
Milwaukee, Wisconsin, United States, 53215
- Aurora St. Luke's Medical Center
-
Milwaukee, Wisconsin, United States, 53211
- Columbia St. Mary's Hospital
-
Milwaukee, Wisconsin, United States, 53226
- Froedtert Memorial Lutheran Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Neurological deficit (based on history or exam) attributed to focal brain ischemia and EITHER:
- High risk TIA: Complete resolution of the deficit at the time of randomization AND ABCD2 score of (greater than or equal to) 4 OR
- Minor ischemic stroke: residual deficit with NIHSS of (less than or equal to) 3 at the time of randomization
- Ability to randomize within 12 hours of time last known free of new ischemic symptoms.
- Head CT or MRI ruling out hemorrhage or other pathology, such as vascular malformation, tumor, or abscess, that could explain symptoms or contraindicate therapy.
- Ability to tolerate aspirin at a does of 50-325 mg/day.
Exclusion Criteria
- Age <18 years
- TIA symptoms limited to isolated numbness, isolated visual changes, or isolated dizziness/vertigo.
- In the judgment of the treating physician, a candidate for thrombolysis, endarterectomy or endovascular intervention, unless the subject declines both endarterectomy and endovascular intervention at the time of evaluation for eligibility.
- Receipt of any intravenous or intra-arterial thrombolysis within 1 week prior to index event.
- Gastrointestinal bleed or major surgery within 3 months prior to index event.
- History of nontraumatic intracranial hemorrhage.
- Clear indication for anticoagulation (e.g., warfarin, heparin) anticipated during the study period (atrial fibrillation, mechanical heart valve, deep venous thrombosis, pulmonary embolism, antiphospholipid antibody syndrome, hypercoagulable state).
- Qualifying ischemic event induced by angiography or surgery.
- Severe non-cardiovascular comorbidity with life expectancy <3 months.
Contraindication to clopidogrel or aspirin.
- Known allergy
- Severe renal (serum creatinine >2 mg/dL or 176.8umol/L) or hepatic insufficiency (prior or concurrent diagnosis, with International Normalized Ratio (INR)>1.5 or any resultant complication, such as variceal bleeding, encephalopathy, or icterus)
- Hemostatic disorder or systemic bleeding in the past 3 months
- Current thrombocytopenia (platelet count <100 x10^9/l) or neutropenia (<1 x10^9/l)
- History of drug-induced hematologic or hepatic abnormalities
- Anticipated requirement for long-term (>7 day) non-study antiplatelet drugs (eg, dipyridamole, clopidogrel, ticlopidine), or Non-steroidal Anti-inflammatory Drugs (NSAIDs) affecting platelet function (such as prior vascular stent or arthritis).
- Inability to swallow medications.
- At risk for pregnancy: premenopausal or post menopausal woman within 12 months of last menses without a negative pregnancy test or not committing to adequate birth control (e.g., oral contraceptive, two methods of barrier birth control, or abstinence).
- Unavailability for follow-up.
- Signed and dated informed consent not obtained from patient.
- Other neurological conditions that would complicate assessment of outcomes during follow-up.
- Ongoing treatment in another study of an investigational therapy that may potentially interact with study drug, or treatment in such a study within the last 7 days.
- Previously enrolled in the POINT study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: clopidogrel
Patients assigned to clopidogrel in addition to aspirin
|
Loading dose of 600mg followed by 75 milligrams, oral, one tablet daily for 89 days
Other Names:
|
|
Placebo Comparator: placebo
Patients assigned to placebo in addition to aspirin
|
Loading dose of 8 tablets followed by one tablet daily for 89 days
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Composite of Ischemic Stroke, Myocardial Infarction, or Death From Ischemic Vascular Causes
Time Frame: Up to 90 days
|
Primary efficacy outcome: Number of Participants with Ischemic Stroke, Myocardial Infarction, or Death From Ischemic Vascular Causes
|
Up to 90 days
|
|
Major Hemorrhage
Time Frame: Up to 90 days
|
Primary safety outcome: Number of Participants with major hemorrhage
|
Up to 90 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Ischemic Stroke
Time Frame: Up to 90 days
|
Secondary efficacy outcome:Number of participants with Ischemic stroke
|
Up to 90 days
|
|
Myocardial Infarction
Time Frame: Up to 90 days
|
Secondary efficacy outcome: Number of participants with Myocardial infarction
|
Up to 90 days
|
|
Death From Ischemic Vascular Causes
Time Frame: Up to 90 days
|
Secondary efficacy outcome: Number of participants with Death from ischemic vascular causes
|
Up to 90 days
|
|
Ischemic or Hemorrhagic Stroke
Time Frame: Up to 90 days
|
Secondary efficacy outcome: Number of participants with Ischemic or hemorrhagic stroke
|
Up to 90 days
|
|
Composite of Ischemic Stroke, Myocardial Infarction, Death From Ischemic Vascular Causes, or Major Hemorrhage
Time Frame: Up to 90 days
|
Secondary efficacy outcome: Number of participants with ischemic stroke, myocardial infarction, death from ischemic vascular causes, or major hemorrhage
|
Up to 90 days
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hemorrhagic Stroke
Time Frame: up to 90 days
|
Other safety outcome: Number of participants with Hemorrhagic stroke
|
up to 90 days
|
|
Symptomatic Intracerebral Hemorrhage
Time Frame: up to 90 days
|
Other safety outcome: Number of participants with Symptomatic intracerebral hemorrhage
|
up to 90 days
|
|
Other Symptomatic Intracranial Hemorrhage
Time Frame: up to 90 days
|
Other safety outcome: Number of participants with other symptomatic intracranial hemorrhage
|
up to 90 days
|
|
Major Hemorrhage Other Than Intracranial Hemorrhage
Time Frame: up to 90 days
|
Other safety outcome: Number of Participants with Major hemorrhage other than intracranial hemorrhage
|
up to 90 days
|
|
Minor Hemorrhage
Time Frame: up to 90 days
|
Other safety outcome:Number of Participants with Minor hemorrhage
|
up to 90 days
|
|
Death From Any Cause
Time Frame: up to 90 days
|
Other safety outcome: Number of Participants with Death from any cause
|
up to 90 days
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: S. Claiborne Johnston, MD, PhD, University of Texas - Austin
- Principal Investigator: J. Donald Easton, MD, University of California, San Francisco
Publications and helpful links
General Publications
- Johnston SC, Gress DR, Browner WS, Sidney S. Short-term prognosis after emergency department diagnosis of TIA. JAMA. 2000 Dec 13;284(22):2901-6. doi: 10.1001/jama.284.22.2901.
- Wang Y, Wang Y, Zhao X, Liu L, Wang D, Wang C, Wang C, Li H, Meng X, Cui L, Jia J, Dong Q, Xu A, Zeng J, Li Y, Wang Z, Xia H, Johnston SC; CHANCE Investigators. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med. 2013 Jul 4;369(1):11-9. doi: 10.1056/NEJMoa1215340. Epub 2013 Jun 26.
- Kennedy J, Hill MD, Ryckborst KJ, Eliasziw M, Demchuk AM, Buchan AM; FASTER Investigators. Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial. Lancet Neurol. 2007 Nov;6(11):961-9. doi: 10.1016/S1474-4422(07)70250-8. Epub 2007 Oct 10.
- Mitsios JV, Papathanasiou AI, Rodis FI, Elisaf M, Goudevenos JA, Tselepis AD. Atorvastatin does not affect the antiplatelet potency of clopidogrel when it is administered concomitantly for 5 weeks in patients with acute coronary syndromes. Circulation. 2004 Mar 23;109(11):1335-8. doi: 10.1161/01.CIR.0000124581.18191.15. Epub 2004 Mar 15.
- Diener HC, Easton JD, Hart RG, Kasner S, Kamel H, Ntaios G. Review and update of the concept of embolic stroke of undetermined source. Nat Rev Neurol. 2022 Aug;18(8):455-465. doi: 10.1038/s41582-022-00663-4. Epub 2022 May 10.
- Eliasziw M, Kennedy J, Hill MD, Buchan AM, Barnett HJ; North American Symptomatic Carotid Endarterectomy Trial Group. Early risk of stroke after a transient ischemic attack in patients with internal carotid artery disease. CMAJ. 2004 Mar 30;170(7):1105-9. doi: 10.1503/cmaj.1030460.
- Luengo-Fernandez R, Gray AM, Rothwell PM. Effect of urgent treatment for transient ischaemic attack and minor stroke on disability and hospital costs (EXPRESS study): a prospective population-based sequential comparison. Lancet Neurol. 2009 Mar;8(3):235-43. doi: 10.1016/S1474-4422(09)70019-5. Epub 2009 Feb 4.
- Lavallee PC, Meseguer E, Abboud H, Cabrejo L, Olivot JM, Simon O, Mazighi M, Nifle C, Niclot P, Lapergue B, Klein IF, Brochet E, Steg PG, Leseche G, Labreuche J, Touboul PJ, Amarenco P. A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects. Lancet Neurol. 2007 Nov;6(11):953-60. doi: 10.1016/S1474-4422(07)70248-X.
- Giles MF, Rothwell PM. Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol. 2007 Dec;6(12):1063-72. doi: 10.1016/S1474-4422(07)70274-0. Epub 2007 Nov 13.
- Wu CM, McLaughlin K, Lorenzetti DL, Hill MD, Manns BJ, Ghali WA. Early risk of stroke after transient ischemic attack: a systematic review and meta-analysis. Arch Intern Med. 2007 Dec 10;167(22):2417-22. doi: 10.1001/archinte.167.22.2417.
- Rothwell PM, Giles MF, Flossmann E, Lovelock CE, Redgrave JN, Warlow CP, Mehta Z. A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack. Lancet. 2005 Jul 2-8;366(9479):29-36. doi: 10.1016/S0140-6736(05)66702-5.
- Wang Y, Johnston SC; CHANCE Investigators. Rationale and design of a randomized, double-blind trial comparing the effects of a 3-month clopidogrel-aspirin regimen versus aspirin alone for the treatment of high-risk patients with acute nondisabling cerebrovascular event. Am Heart J. 2010 Sep;160(3):380-386.e1. doi: 10.1016/j.ahj.2010.05.017.
- Lovett JK, Dennis MS, Sandercock PA, Bamford J, Warlow CP, Rothwell PM. Very early risk of stroke after a first transient ischemic attack. Stroke. 2003 Aug;34(8):e138-40. doi: 10.1161/01.STR.0000080935.01264.91. Epub 2003 Jul 10.
- Ovbiagele B. Antiplatelet therapy in management of transient ischemic attack: overview and evidence-based rationale. J Emerg Med. 2008 May;34(4):389-96. doi: 10.1016/j.jemermed.2007.08.056. Epub 2008 Jan 18.
- Kernan WN, Schindler JL. Rapid intervention for TIA: a new standard emerges. Lancet Neurol. 2007 Nov;6(11):940-1. doi: 10.1016/S1474-4422(07)70249-1. No abstract available.
- Rothwell PM. Transient ischaemic attacks: time to wake up. Heart. 2007 Aug;93(8):893-4. doi: 10.1136/hrt.2007.121111.
- Streifler JY. Early stroke risk after a transient ischemic attack: can it be minimized? Stroke. 2008 Jun;39(6):1655-6. doi: 10.1161/STROKEAHA.107.510248. Epub 2008 Mar 27. No abstract available.
- Dean N, Shuaib A. Transient ischaemic attacks: unstable, treatable, neglected. Lancet. 2007 Oct 20;370(9596):1398-400. doi: 10.1016/S0140-6736(07)61449-4. No abstract available.
- Geisler T, Zurn C, Paterok M, Gohring-Frischholz K, Bigalke B, Stellos K, Seizer P, Kraemer BF, Dippon J, May AE, Herdeg C, Gawaz M. Statins do not adversely affect post-interventional residual platelet aggregation and outcomes in patients undergoing coronary stenting treated by dual antiplatelet therapy. Eur Heart J. 2008 Jul;29(13):1635-43. doi: 10.1093/eurheartj/ehn212. Epub 2008 May 24.
- Lotfi A, Schweiger MJ, Giugliano GR, Murphy SA, Cannon CP; TIMI 22 Investigators. High-dose atorvastatin does not negatively influence clinical outcomes among clopidogrel treated acute coronary syndrome patients--a Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) analysis. Am Heart J. 2008 May;155(5):954-8. doi: 10.1016/j.ahj.2007.12.009. Epub 2008 Feb 19.
- Riondino S, Petrini N, Donato L, Torromeo C, Tanzilli G, Pulcinelli FM, Barilla F. Effects of rosuvastatin on platelet inhibition by clopidogrel in cardiovascular patients. J Thromb Thrombolysis. 2009 Aug;28(2):151-5. doi: 10.1007/s11239-008-0254-6. Epub 2008 Jul 18.
- Saw J, Brennan DM, Steinhubl SR, Bhatt DL, Mak KH, Fox K, Topol EJ; CHARISMA Investigators. Lack of evidence of a clopidogrel-statin interaction in the CHARISMA trial. J Am Coll Cardiol. 2007 Jul 24;50(4):291-5. doi: 10.1016/j.jacc.2007.01.097. Epub 2007 Jul 10.
- Saw J, Steinhubl SR, Berger PB, Kereiakes DJ, Serebruany VL, Brennan D, Topol EJ; Clopidogrel for the Reduction of Events During Observation Investigators. Lack of adverse clopidogrel-atorvastatin clinical interaction from secondary analysis of a randomized, placebo-controlled clopidogrel trial. Circulation. 2003 Aug 26;108(8):921-4. doi: 10.1161/01.CIR.0000088780.57432.43. Epub 2003 Aug 18.
- Trenk D, Hochholzer W, Frundi D, Stratz C, Valina CM, Bestehorn HP, Buttner HJ, Neumann FJ. Impact of cytochrome P450 3A4-metabolized statins on the antiplatelet effect of a 600-mg loading dose clopidogrel and on clinical outcome in patients undergoing elective coronary stent placement. Thromb Haemost. 2008 Jan;99(1):174-81. doi: 10.1160/TH07-08-0503.
- Coutts SB, Eliasziw M, Hill MD, Scott JN, Subramaniam S, Buchan AM, Demchuk AM; VISION study group. An improved scoring system for identifying patients at high early risk of stroke and functional impairment after an acute transient ischemic attack or minor stroke. Int J Stroke. 2008 Feb;3(1):3-10. doi: 10.1111/j.1747-4949.2008.00182.x.
- Coutts SB, Simon JE, Eliasziw M, Sohn CH, Hill MD, Barber PA, Palumbo V, Kennedy J, Roy J, Gagnon A, Scott JN, Buchan AM, Demchuk AM. Triaging transient ischemic attack and minor stroke patients using acute magnetic resonance imaging. Ann Neurol. 2005 Jun;57(6):848-54. doi: 10.1002/ana.20497.
- Algra A, van Gijn J, Halkes PH, Kappelle LJ, Koudstaal PJ; ESPRIT Study Group. Interpretation of ESPRIT in the FASTER trial. Lancet Neurol. 2008 Mar;7(3):198-9; author reply 199. doi: 10.1016/S1474-4422(08)70030-9. No abstract available.
- Yusuf S, Diener HC, Sacco RL, Cotton D, Ounpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, Bornstein N, Chan BP, Chen ST, Cunha L, Dahlof B, De Keyser J, Donnan GA, Estol C, Gorelick P, Gu V, Hermansson K, Hilbrich L, Kaste M, Lu C, Machnig T, Pais P, Roberts R, Skvortsova V, Teal P, Toni D, VanderMaelen C, Voigt T, Weber M, Yoon BW; PRoFESS Study Group. Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med. 2008 Sep 18;359(12):1225-37. doi: 10.1056/NEJMoa0804593. Epub 2008 Aug 27.
- Sacco RL, Diener HC, Yusuf S, Cotton D, Ounpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, Bornstein N, Chan BP, Chen ST, Cunha L, Dahlof B, De Keyser J, Donnan GA, Estol C, Gorelick P, Gu V, Hermansson K, Hilbrich L, Kaste M, Lu C, Machnig T, Pais P, Roberts R, Skvortsova V, Teal P, Toni D, Vandermaelen C, Voigt T, Weber M, Yoon BW; PRoFESS Study Group. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med. 2008 Sep 18;359(12):1238-51. doi: 10.1056/NEJMoa0805002. Epub 2008 Aug 27.
- Brown RD Jr, Petty GW, O'Fallon WM, Wiebers DO, Whisnant JP. Incidence of transient ischemic attack in Rochester, Minnesota, 1985-1989. Stroke. 1998 Oct;29(10):2109-13. doi: 10.1161/01.str.29.10.2109.
- Kissela B, Broderick J, Woo D, Kothari R, Miller R, Khoury J, Brott T, Pancioli A, Jauch E, Gebel J, Shukla R, Alwell K, Tomsick T. Greater Cincinnati/Northern Kentucky Stroke Study: volume of first-ever ischemic stroke among blacks in a population-based study. Stroke. 2001 Jun;32(6):1285-90. doi: 10.1161/01.str.32.6.1285.
- Williams GR, Jiang JG, Matchar DB, Samsa GP. Incidence and occurrence of total (first-ever and recurrent) stroke. Stroke. 1999 Dec;30(12):2523-8. doi: 10.1161/01.str.30.12.2523.
- Kleindorfer D, Panagos P, Pancioli A, Khoury J, Kissela B, Woo D, Schneider A, Alwell K, Jauch E, Miller R, Moomaw C, Shukla R, Broderick JP. Incidence and short-term prognosis of transient ischemic attack in a population-based study. Stroke. 2005 Apr;36(4):720-3. doi: 10.1161/01.STR.0000158917.59233.b7. Epub 2005 Feb 24.
- Edlow JA, Kim S, Pelletier AJ, Camargo CA Jr. National study on emergency department visits for transient ischemic attack, 1992-2001. Acad Emerg Med. 2006 Jun;13(6):666-72. doi: 10.1197/j.aem.2006.01.014. Epub 2006 Apr 11.
- Howard G, Toole JF, Frye-Pierson J, Hinshelwood LC. Factors influencing the survival of 451 transient ischemic attack patients. Stroke. 1987 May-Jun;18(3):552-7. doi: 10.1161/01.str.18.3.552.
- Shah KH, Kleckner K, Edlow JA. Short-term prognosis of stroke among patients diagnosed in the emergency department with a transient ischemic attack. Ann Emerg Med. 2008 Mar;51(3):316-23. doi: 10.1016/j.annemergmed.2007.08.016. Epub 2007 Oct 25. Erratum In: Ann Emerg Med. 2008 Jun;51(6):774.
- Gladstone DJ, Kapral MK, Fang J, Laupacis A, Tu JV. Management and outcomes of transient ischemic attacks in Ontario. CMAJ. 2004 Mar 30;170(7):1099-104. doi: 10.1503/cmaj.1031349.
- Lisabeth LD, Ireland JK, Risser JM, Brown DL, Smith MA, Garcia NM, Morgenstern LB. Stroke risk after transient ischemic attack in a population-based setting. Stroke. 2004 Aug;35(8):1842-6. doi: 10.1161/01.STR.0000134416.89389.9d. Epub 2004 Jun 10.
- Hill MD, Yiannakoulias N, Jeerakathil T, Tu JV, Svenson LW, Schopflocher DP. The high risk of stroke immediately after transient ischemic attack: a population-based study. Neurology. 2004 Jun 8;62(11):2015-20. doi: 10.1212/01.wnl.0000129482.70315.2f.
- Rao SV, Ohman EM, Granger CB, Armstrong PW, Gibler WB, Christenson RH, Hasselblad V, Stebbins A, McNulty S, Newby LK. Prognostic value of isolated troponin elevation across the spectrum of chest pain syndromes. Am J Cardiol. 2003 Apr 15;91(8):936-40. doi: 10.1016/s0002-9149(03)00107-3.
- Whisnant JP, Matsumoto N, Elveback LR. Transient cerebral ischemic attacks in a community. Rochester, Minnesota, 1955 through 1969. Mayo Clin Proc. 1973 Mar;48(3):194-8. No abstract available.
- Humphrey PR, Marshall J. Transient ischemic attacks and strokes with recovery prognosis and investigation. Stroke. 1981 Nov-Dec;12(6):765-9. doi: 10.1161/01.str.12.6.765.
- Putman SF, Adams HP Jr. Usefulness of heparin in initial management of patients with recent transient ischemic attacks. Arch Neurol. 1985 Oct;42(10):960-2. doi: 10.1001/archneur.1985.04060090042011.
- Biller J, Bruno A, Adams HP Jr, Godersky JC, Loftus CM, Mitchell VL, Banwart KJ, Jones MP. A randomized trial of aspirin or heparin in hospitalized patients with recent transient ischemic attacks. A pilot study. Stroke. 1989 Apr;20(4):441-7. doi: 10.1161/01.str.20.4.441.
- Dennis M, Bamford J, Sandercock P, Warlow C. Prognosis of transient ischemic attacks in the Oxfordshire Community Stroke Project. Stroke. 1990 Jun;21(6):848-53. doi: 10.1161/01.str.21.6.848.
- Coull AJ, Lovett JK, Rothwell PM; Oxford Vascular Study. Population based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services. BMJ. 2004 Feb 7;328(7435):326. doi: 10.1136/bmj.37991.635266.44. Epub 2004 Jan 26.
- Daffertshofer M, Mielke O, Pullwitt A, Felsenstein M, Hennerici M. Transient ischemic attacks are more than "ministrokes". Stroke. 2004 Nov;35(11):2453-8. doi: 10.1161/01.STR.0000144050.90132.8e. Epub 2004 Oct 14.
- Whitehead MA, McManus J, McAlpine C, Langhorne P. Early recurrence of cerebrovascular events after transient ischaemic attack. Stroke. 2005 Jan;36(1):1; author reply 1. doi: 10.1161/01.str.0000149929.92356.f1. No abstract available.
- Correia M, Silva MR, Magalhaes R, Guimaraes L, Silva MC. Transient ischemic attacks in rural and urban northern Portugal: incidence and short-term prognosis. Stroke. 2006 Jan;37(1):50-5. doi: 10.1161/01.STR.0000195209.26543.8f. Epub 2005 Dec 1.
- Purroy F, Molina CA, Montaner J, Alvarez-Sabin J. Absence of usefulness of ABCD score in the early risk of stroke of transient ischemic attack patients. Stroke. 2007 Mar;38(3):855-6; author reply 857. doi: 10.1161/01.STR.0000257306.00512.d3. Epub 2007 Jan 18. No abstract available.
- Mac Grory B, Piccini JP, Yaghi S, Poli S, De Havenon A, Rostanski SK, Weiss M, Xian Y, Johnston SC, Feng W. Hyperglycemia, Risk of Subsequent Stroke, and Efficacy of Dual Antiplatelet Therapy: A Post Hoc Analysis of the POINT Trial. J Am Heart Assoc. 2022 Feb;11(3):e023223. doi: 10.1161/JAHA.121.023223. Epub 2022 Jan 19.
- Meschia JF, Walton RL, Farrugia LP, Ross OA, Elm JJ, Farrant M, Meurer WJ, Lindblad AS, Barsan W, Ching M, Gentile N, Ross M, Nahab F, Easton JD, Kim AS, Zurita KG, Cucchiara B, Johnston SC. Efficacy of Clopidogrel for Prevention of Stroke Based on CYP2C19 Allele Status in the POINT Trial. Stroke. 2020 Jul;51(7):2058-2065. doi: 10.1161/STROKEAHA.119.028713. Epub 2020 Jun 17.
- Kamel H, Zhang C, Kleindorfer DO, Levitan EB, Howard VJ, Howard G, Soliman EZ, Johnston SC. Association of Black Race With Early Recurrence After Minor Ischemic Stroke or Transient Ischemic Attack: Secondary Analysis of the POINT Randomized Clinical Trial. JAMA Neurol. 2020 May 1;77(5):601-605. doi: 10.1001/jamaneurol.2020.0010.
- Cucchiara B, Elm J, Easton JD, Coutts SB, Willey JZ, Biros MH, Ross MA, Johnston SC. Disability After Minor Stroke and Transient Ischemic Attack in the POINT Trial. Stroke. 2020 Mar;51(3):792-799. doi: 10.1161/STROKEAHA.119.027465. Epub 2020 Feb 12.
- Farrant M, Easton JD, Adelman EE, Cucchiara BL, Barsan WG, Tillman HJ, Elm JJ, Kim AS, Lindblad AS, Palesch YY, Zhao W, Pauls K, Walsh KB, Marti-Fabregas J, Bernstein RA, Johnston SC. Assessment of the End Point Adjudication Process on the Results of the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: A Secondary Analysis. JAMA Netw Open. 2019 Sep 4;2(9):e1910769. doi: 10.1001/jamanetworkopen.2019.10769.
- Johnston SC, Elm JJ, Easton JD, Farrant M, Barsan WG, Kim AS, Lindblad AS, Palesch YY, Zurita KG, Albers GW, Cucchiara BL, Kleindorfer DO, Lutsep HL, Pearson C, Sethi P, Vora N; POINT and Neurological Emergencies Treatment Trials Network Investigators. Time Course for Benefit and Risk of Clopidogrel and Aspirin After Acute Transient Ischemic Attack and Minor Ischemic Stroke. Circulation. 2019 Aug 20;140(8):658-664. doi: 10.1161/CIRCULATIONAHA.119.040713. Epub 2019 Jun 26.
- Tillman H, Johnston SC, Farrant M, Barsan W, Elm JJ, Kim AS, Lindblad AS, Palesch YY, Easton JD. Risk for Major Hemorrhages in Patients Receiving Clopidogrel and Aspirin Compared With Aspirin Alone After Transient Ischemic Attack or Minor Ischemic Stroke: A Secondary Analysis of the POINT Randomized Clinical Trial. JAMA Neurol. 2019 Jul 1;76(7):774-782. doi: 10.1001/jamaneurol.2019.0932.
- Johnston SC, Easton JD, Farrant M, Barsan W, Conwit RA, Elm JJ, Kim AS, Lindblad AS, Palesch YY; Clinical Research Collaboration, Neurological Emergencies Treatment Trials Network, and the POINT Investigators. Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA. N Engl J Med. 2018 Jul 19;379(3):215-225. doi: 10.1056/NEJMoa1800410. Epub 2018 May 16.
- Zhao W, Pauls K. Architecture design of a generic centralized adjudication module integrated in a web-based clinical trial management system. Clin Trials. 2016 Apr;13(2):223-33. doi: 10.1177/1740774515611889. Epub 2015 Oct 13.
- Johnston SC, Easton JD, Farrant M, Barsan W, Battenhouse H, Conwit R, Dillon C, Elm J, Lindblad A, Morgenstern L, Poisson SN, Palesch Y. Platelet-oriented inhibition in new TIA and minor ischemic stroke (POINT) trial: rationale and design. Int J Stroke. 2013 Aug;8(6):479-83. doi: 10.1111/ijs.12129.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Pathologic Processes
- Cardiovascular Diseases
- Vascular Diseases
- Cerebrovascular Disorders
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Brain Ischemia
- Stroke
- Ischemic Stroke
- Ischemia
- Ischemic Attack, Transient
- Physiological Effects of Drugs
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Platelet Aggregation Inhibitors
- Purinergic P2Y Receptor Antagonists
- Purinergic P2 Receptor Antagonists
- Purinergic Antagonists
- Purinergic Agents
- Clopidogrel
Other Study ID Numbers
- 1U01S062835-01A1
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.